In this interview I spoke with Dr. Franjo Grotenhermen who is Executive Director of the International Association for Cannabinoid Medicines and organizer of the 2019 Cannabinoids in Medicine conference in Berlin, Germany.

Dr. Grotenhermen treats many patients using high-THC cannabis, including over 300 with ADHD and some with schizophrenia. At the conference he shared his experience and expertise with doctors from 35 countries, and he kindly shared shared some with us.

Dr. Grotenhemen explained potential drug interactions. He also addressed possible acute side-effects like psychosis, and possible chronic side-effects like dependency and schizophrenia. He explained these are insignificant when put in perspective.

He also shared research that indicates many medical conditions may originate in the endocannabinoid system (which cannabis helps regulate), and research into THC as an anticancer agent.

Doctors interested in prescribing cannabis medicines can attend an upcoming 4hr Seminar "My first patient" by Dr. Franjo Grotenhermen in English, in Amsterdam from 3pm this Wednesday November 27th. His talk is presented by pharmaceutical-grade cannabis manufacturer MYCB1. Info at https://mycb1.com/seminar.

#doctor #cannabis #medical #cannabismedicinal #research #healthcare #drfranjogrotenhermen

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy